Company news

PYC Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

First Competitive Read Out - Peptide Vaccine

February 8, 2019

Dec 2018 Operational Update and App4C

January 31, 2019

CEO letter and Operational Update

January 16, 2019

In Vivo Success - peptide vaccine (Amended Graphics)

December 6, 2018

In vivo success - peptide vaccine in Herpes Simplex Virus

December 6, 2018

Successful Delivery of CRIPR/Cas9 into Cells ex vivo

December 3, 2018

FNA Presentation

November 22, 2018

AGM Company Presentation

November 16, 2018

Sept 2018 Quarterly Operations Update and App4C

October 31, 2018

Fourfold Delivery Improvement in a New Lead Candidate

October 29, 2018

R&D Tax Incentive Refund

October 8, 2018

Reinstatement to Official Quotation

September 11, 2018

Phylogica Recapitalisation

September 11, 2018

Suspension from Official Quotation

September 10, 2018

Update on Capital Raising

September 10, 2018

June 2018 Quarterly Operational Update and App4C

July 31, 2018

Achievement of Major Milestone - In vivo Cre Delivery

July 30, 2018

Successful In-vivo Results Peptide Vaccine T-Cell Expansion

July 26, 2018

CEO Update

July 8, 2018

March 2018 Operational Update and Cashflow

April 30, 2018

Changes to Board and Management

April 11, 2018

Cre Enzyme Delivery Provides Validation & Strategic Value

March 1, 2018

Dec 2017 Half-year financial statements & Appendix 4D

February 28, 2018

Dec Quarterly Update and Appendix 4C

January 31, 2018

Federal R&D Tax Credit Received

January 11, 2018

FPP Results Effective in Delivering Peptide Cancer Vaccine

January 8, 2018

Phylogica Strategic Update - Pivot to Platform

December 3, 2017

Quarterly Update and Appendix 4C

October 25, 2017

PYC Granted US Patent for Peptides Entering Brain Cells

October 4, 2017

New Delivery Vehicles Show Improved Performance Inside Cells

September 5, 2017

Appendix 4E - Preliminary Final Report 30 June 2017

August 31, 2017

Response to ASX Query

July 24, 2017

Operational Update June quarter

July 10, 2017

CEO and CSO Appointments

June 18, 2017

Operational Update March Quarter

April 4, 2017

Response to ASX Price Query

January 30, 2017

Genentech extends research collaboration period

December 18, 2016

NHMRC Grant Awarded to Collaborators

December 5, 2016

AGM Presentation to Shareholders

November 25, 2016

Shareholder Update

September 29, 2016

Operational Update

July 27, 2016

Chief Executive Officer Resignation

July 18, 2016

Cell-Penetrating Phylomers Improve Delivery of Drugs

June 15, 2016

R&D Tax Rebate

March 30, 2016

Phylogica Signs Agreement with MedImmune / AstraZeneca

March 30, 2016

Phylogica - New Potential For Treating Brain Injury

March 30, 2016

Phylogica Accesses Novel Half-Life Extension Technology

March 30, 2016

Technology Licence to Janssen Biotech

March 30, 2016

Share Placement raises $2.15 Million

March 30, 2016

Pfizer First Stage of Collaboration Complete

March 30, 2016

← Newer news releases · Older news releases →

Decks

The 5 newest of 99 decks. Every deck is listed under its year.